Use of phospholamban inhibitors for increasing coronary flow

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/14 (2006.01) A61K 31/00 (2006.01) A61K 31/41 (2006.01) A61K 31/47 (2006.01) C07D 215/227 (2006.01) C07D 405/14 (2006.01) C07D 413/14 (2006.01)

Patent

CA 2294550

A method for obtaining direct dilatation of the coronary arteries by administering a therapeutically effective amount of a phospholamban inhibitor is described. Compounds which are effective in relieving the inhibitory effects of phospholamban on cardiac sarcoplasmic reticulum Ca2+-ATPase are also described.

L'invention concerne un procédé permettant d'obtenir une dilatation directe des artères coronaires grâce à l'administration d'une quantité thérapeutiquement efficace d'un inhibiteur de phospholamban. L'invention concerne également des composés permettant de soulager efficacement les effets inhibiteurs du phospholamban sur la Ca?2+¿-ATPase du réticulum sarcoplasmique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of phospholamban inhibitors for increasing coronary flow does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of phospholamban inhibitors for increasing coronary flow, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of phospholamban inhibitors for increasing coronary flow will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1898897

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.